Neuromodulation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Neuromodulation Devices Market is Segmented by Technology (Internal Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimulation) and External Neuromodulation (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, and Others)), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

Neuromodulation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Neuromodulation Industry Overview

The neuromodulation market is moderately competitive. The increasing innovation and investment for various public and private organizations are expected to intensify industry rivalry worldwide. The major industry players in the market include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Synapse Biomedical Inc., and Nevro Corporation, among others.

Neuromodulation Market Leaders

  1. Boston Scientific Corporation

  2. Abbott Laboratories

  3. Synapse Biomedical Inc.

  4. Medtronic PLC

  5. Nevro Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Neuromodulation Market Concentration